BioROSA

Boston, MALife SciencesCohort: 2019-2020

BioROSA is developing a blood-based diagnostic and therapeutic platform for Autism Spectrum Disorder (ASD) and related pathologies. BioROSA’s technology combines a novel targeted metabolic approach with machine learning to achieve superior accuracy and potentially shrink diagnostic timelines by over three years.

biorosa.com